The American Society of Cataract and Refractive Surgery (ASCRS) and the AAQ have jointly issued a patient advisory on alpha-blockers, especially on tamsulosin (Flomax; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT).
The advisory states that the alpha-adrenergic receptor blocker (tamsulosin), commonly used in the treatment of benign prostatic hyperplasia (BPH), is responsible for certain surgical complications. These arise due to intraoperative floppy iris syndrome (IFIS). Patients taking tamsulosin are additionally at a 2.3 time higher risk of severe postoperative complications, like retinal detachment and lost lens fragments.
Advertisement
Patients who have been prescribed, or have any history of alpha-blocker use, must report the same to their ophthalmologists, advise the two leading ophthalmic organizations, as the drug may increase chances of complications following eye surgery. However, the advisory also reassures patients that despite such drug history, the success rate of cataract surgery hasn't diminished. Patients need not delay recommended eye surgery, fearing complications.
Source: Medindia
TAN
Cataract - Animation
An animation of how cataract of the lens can cause blurring of images on the retina.
Advertisement
 Cataract Surgery - AnimationAn Illustration of the Cataract surgery that is performed to restore the sight for the patients suffering from cataract, which is a loss of transparency in the eye's lens. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
